Status:
COMPLETED
Evaluating the Implementation of the Diabetes Prevention Program in an Integrated Health System
Lead Sponsor:
Kaiser Permanente
Conditions:
Diabetes
Eligibility:
All Genders
19-75 years
Brief Summary
In preparation for the roll out of the Medicare Diabetes Prevention Program (DPP) in 2018, Kaiser Permanente Northwest (KPNW), a large, integrated health care system, plans to pilot the implementation...
Detailed Description
The prevalence of prediabetes and obesity among U.S. adults age 40 and older is significant, with over 30% having prediabetes and over 40% having obesity.\[1,2\] Prediabetes and obesity increase the r...
Eligibility Criteria
Inclusion
- Age 19-75
- BMI ≥ 30; and
- HbA1c 5.7-6.4%.
Exclusion
- 1\) Diagnosis of diabetes prior to the study's recruitment efforts
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2021
Estimated Enrollment :
8198 Patients enrolled
Trial Details
Trial ID
NCT03249077
Start Date
July 1 2017
End Date
April 15 2021
Last Update
June 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Center for Health Research
Portland, Oregon, United States, 97227